NEW YORK (GenomeWeb News) – Opko Health today announced it has granted UK-based International Health Technology the rights to offer a novel panel of protein biomarkers and an associated algorithm in parts of Europe for the detection of prostate cancer.

Under the terms of the deal, IHT will offer the biomarker panel in laboratory settings in the UK, Ireland, Sweden, and Denmark. Financial and other terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.